Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

crawled time : 11:00    source : Ir.zynerba.com    save search

Zynerba Pharmaceuticals Announces Poster Presentation at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit
Published: 2022-10-10 (Crawled : 11:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 0.03% C: -5.56%

rare pharmaceuticals presentation
Zynerba Pharmaceuticals Announces Issuance of New U.S. Patent for Zygel™
Published: 2022-10-06 (Crawled : 11:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 13.42% C: 12.96%

pharmaceuticals patent
Zynerba Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
Published: 2022-09-29 (Crawled : 11:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: -1.21% H: 1.18% C: -7.99%

pharmaceuticals conference
Zynerba Pharmaceuticals to Present at the Ladenburg Thalmann Healthcare Conference
Published: 2022-09-22 (Crawled : 11:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: 0.4% H: 3.25% C: 1.25%

pharmaceuticals conference
Zynerba Pharmaceuticals to Present In-Person at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-06 (Crawled : 11:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 0.0% C: -1.77%

global conference
Zynerba Pharmaceuticals Announces Oral Presentation at The Society for the Study of Behavioural Phenotypes (SSBP) 24th International Research Symposium
Published: 2022-08-31 (Crawled : 11:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: 1.74% H: 0.61% C: 0.0%

research symposium presentation international study
Zynerba Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Highlights
Published: 2022-08-10 (Crawled : 11:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: 4.17% H: 9.6% C: 0.0%

results
Zynerba Pharmaceuticals to Present In Person at the Canaccord Genuity 42nd Annual Growth Conference
Published: 2022-08-03 (Crawled : 11:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: 1.79% H: 4.39% C: 2.63%

conference growth
Zynerba Pharmaceuticals Announces Panel Presentation and Poster Presentations at the NFXF International Fragile X Conference
Published: 2022-07-07 (Crawled : 11:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: 0.87% H: 5.17% C: 0.86%

conference presentation international
Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
Published: 2022-05-16 (Crawled : 11:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: 6.35% H: 3.3% C: 2.2%

results
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.